Yatiri Bio Inc. Email Format

Biotechnology ResearchCalifornia, United States11-50 Employees

Yatiri Bio Inc. is a biotechnology research company focused on improving cancer drug discovery by narrowing the gap between discovery and clinical application. Acknowledging substantial heterogeneity among cancer patients, the company aims to move beyond traditional models that frequently fail in translation. Its approach combines unbiased molecular profiling with computational analysis and patient-derived cellular systems to define a molecular landscape of patients and empirically testable cell-based models, enabling identification of patient subsets most likely to respond to new therapies. This translational framework seeks to reduce costly late-stage failures by aligning therapeutics with the right patient groups.

Based in San Diego, California, Yatiri Bio operates within the biotechnology research sector serving pharmaceutical and biotech developers pursuing precision oncology solutions. The company has partnered with Ordaos Bio on a joint development agreement to create AML therapeutics, and in March 2026 it announced an exclusive global option to license with Oscotec to develop denfivontinib (SKI-G-801) for AML.

Sign up for free to view info

Company overview Employee directory